Brain potential indices of novelty processing are associated with preference for amphetamine

Area of Science:

• Neuroscience
• Psychopharmacology
• Cognitive Science

Background:

• Individual differences in drug preference exist.
• d-amphetamine affects cognitive processes.
• Event-related potentials (ERPs) measure brain activity.

Purpose of the Study:

• To investigate how d-amphetamine affects brain activity in individuals with different drug preferences.
• To explore the neural basis of attention and orienting responses in relation to drug preference.

Main Methods:

• Behavioral drug preference task to categorize participants.
• Administration of d-amphetamine (10, 15 mg) and placebo.
• Recording of event-related potentials (ERPs) during oddball tasks.

Main Results:

• d-amphetamine enhanced P3a (orienting response) in d-amphetamine choosers, but not placebo choosers.
• Nonchoosers showed larger N100 (attention) and reorienting negativity (RON) than choosers, unaffected by d-amphetamine.
• These differences suggest distinct attentional and attentional re-engagement mechanisms between groups.

Conclusions:

• Group differences in ERPs (P3a, N100, RON) reflect distinct neural processing related to drug preference.
• Findings suggest a balance between dopamine and cholinergic systems influences these processing differences.
• ERPs offer a valuable tool for understanding individual differences relevant to addiction vulnerability.